Liyan Qiu

Bronchoscopic local instillation of amphotericin B deoxycholate as adjunctive therapy for pulmonary mucormycosis with inadequate response to posaconazole: a retrospective case series

Liyan Qiu, Binyue Liang, Hua Zhou

Background: Pulmonary mucormycosis is a life-threatening invasive fungal infection, most often affecting immunocompromised patients. Liposomal amphotericin B is the preferred first-line therapy, but amphotericin B formulations may be poorly tolerated. When endobronchial obstruction and tissue necrosis are present, pulmonary lesions may progress …

cn (code pays fourni par la source)

Analysis of latent profiles and influencing factors of information overload in day surgery patients

Liyan Qiu, Mei Yang, Feng Su, Liping Ma et autres

Background Day surgery has become an increasingly important model of healthcare delivery and offers clear benefits to patients. However, because hospitalization, surgery, and discharge occur within a very short period, patients are required to absorb a large amount of medical information in …

cn (code pays fourni par la source)

ROS-responsive oligochitosan-derived nanovesicles with synergistic oxidative stress and autophagy inhibition for potent tumor therapy

Mingxiao Shao, Peng Yan, Liyan Qiu

cn, nz (code pays fourni par la source)

The clinical utility of bronchoalveolar lavage fluid metagenomic next-generation sequencing in immunocompromised critically ill patients with invasive pulmonary aspergillosis: a multicenter retrospective study

Junjie Zhao, Runxi Zhuge, Kai Guo, Jing Tang et autres

ABSTRACT The clinical utility of metagenomic next-generation sequencing (mNGS) in immunocompromised critically ill patients with invasive pulmonary aspergillosis (IPA) remains poorly studied. Given the diagnostic challenges and high mortality associated with IPA in this population, further research on the use of mNGS …

cn, kr (code pays fourni par la source)

Alkaline phosphatase-responsive lipid-like polyphosphonitrile nanovesicles to enhance immunotherapy and inhibit metastasis of triple-negative breast cancer

Xinchen Zhao, Liyan Qiu

cn (code pays fourni par la source)

Clinical impact of bronchoalveolar lavage fluid metagenomic next-generation sequencing in immunocompromised patients with severe community-acquired pneumonia in ICU: a multicenter retrospective study

Junjie Zhao, Runxi Zhuge, Bangchuan Hu, Yesong Wang et autres

BACKGROUND: An increasing number of critically ill patients are immunocompromised. These patients are at high risk of intensive care unit (ICU) admission because of numerous complications. Acute respiratory failure due to severe community-acquired pneumonia (SCAP) is one of the leading causes of …

cn (code pays fourni par la source)

PDGFR-targeted nanovesicles for restraining breast cancer hepatic metastasis via hepatic stellate cell regression and NK cell activation

Mengjie Kong, Yan Peng, Yujie Miao, Liyan Qiu

cn (code pays fourni par la source)

Relation between frailty and adverse outcomes in elderly patients with gastric cancer: a scoping review

Zheng-Ke-Ke Tan, Wen-Zhen Tang, Kui Jia, Danni Li et autres

Background: Playing an exemplary role, frailty have crucial effect on the preoperative evaluation of elderly patients. Previous studies have shown that frailty is associated with complications and mortality in patients with gastric cancer (GC). However, with the development of the concept of …

cn, gb (code pays fourni par la source)

Prevalence and unfavorable outcome of frailty in older adults with gastric cancer: a systematic review and meta-analysis

Wen-Zhen Tang, Zheng-Ke-Ke Tan, Liyan Qiu, Junqiang Chen et autres

cn (code pays fourni par la source)

Supplementary Figure S4 from Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade

Yu Zhao, Hang Li, Yingyi Zhang, Leilei Li et autres

HBXIP directly binds to LXRs/RXRα to activate SREBP-1c promoter.

Supplementary Figure S3 from Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade

Yu Zhao, Hang Li, Yingyi Zhang, Leilei Li et autres

HBXIP occupies LXRE in SREBP-1c promoter involving LXRs.

Supplementary Figure S6 from Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade

Yu Zhao, Hang Li, Yingyi Zhang, Leilei Li et autres

HBXIP modulates abnormal lipid metabolism of breast cancer cells through a HBXIP/LXRs/SREBP-1c/FAS signaling.